Bruce L. Riser

3.4k citations

53 papers · 2.8k indexed · h-index 31

Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes 9
- Parathyroid Disorders and Treatments 7
Clinical Biochemistry top 2%
Immunology and Allergy top 5%
Molecular Biology top 5%
- Connective Tissue Growth Factor Research 21
- Angiogenesis and VEGF in Cancer 5
- TGF-β signaling in diseases 5
Endocrinology, Diabetes and Metabolism top 5%
Immunology
- Biomarkers in Disease Mechanisms 4
Rehabilitation
- Wound Healing and Treatments 4
Rheumatology
- Heterotopic Ossification and Related Conditions 3

Co-authors: Pedro Cortés Robert G. Narins Jerry Yee James Varani Vishva M. Dixit Mark DeNichilo R S Mitra B J Nickoloff
Cited by: Nephrology Clinical Biochemistry Immunology and Allergy
Journals: Kidney International (10 papers)Journal of Clinical Investigation (3 papers)Journal of Cell Communication and Signaling (3 papers)
Partner nations: United States France Canada

In The Last Decade

Bruce L. Riser

52 papers receiving 2.8k citations

Peers

Countries citing papers authored by Bruce L. Riser

Since Specialization

Citations

This map shows the geographic impact of Bruce L. Riser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce L. Riser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce L. Riser more than expected).

Fields of papers citing papers by Bruce L. Riser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce L. Riser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce L. Riser. The network helps show where Bruce L. Riser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bruce L. Riser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce L. Riser Line = papers co-authored together Bruce L. Riser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The role of yes activated protein (YAP) in melanoma metastasis iScience ·Andrew Leask,John Nguyen,S. A. Leonard,Ana Maria Zapata-Franco,Bruce L. Riser	2024	9
2	Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease? Calcified Tissue International ·Ellen Neven,Britt Opdebeeck,Annelies De Maré,J. P. Doval,Geert Dams,Y Frignac,Geert J. Behets,Anja Verhulst,Bruce L. Riser,Patrick C. D’Haese	2016	7
3	Peritoneal Delivery of Sodium Pyrophosphate Blocks the Progression of Pre-existing Vascular Calcification in Uremic Apolipoprotein-E Knockout Mice Calcified Tissue International ·Rodrigo Cardoso de Oliveira,Loı̈c Louvet,Bruce L. Riser,Fellype Carvalho Barreto,吴顺仙,Raja Rezg,Mohammed Danish Siddiqi,Vanda Jorgetti,Tilman B. Drüeke,Ziad A. Massy	2015	13
4	Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor PLoS ONE ·Alferso C Abrahams,隆生吉兼,Amélie Dendooven,Bruce L. Riser,Lauren Fovargue,Raechel J. Toorop,Michiel G.H. Betjes,Marianne C. Verhaar,Christopher J.E. Watson,Tri Q. Nguyen,Walther H. Boer	2014	27
5	Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy American Journal Of Pathology ·Bruce L. Riser,Feridoon Najmabadi,吉雄渡辺,Jeffrey L. Barnes,Darryl R. Peterson,Bosmann Andreas	2014	32
6	CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure Journal of Molecular and Cellular Cardiology ·Tatiana Tsoutsman,Xiaoyu Wang,吉雄渡辺,Bruce L. Riser,Stephen M. Twigg,Christopher Semsarian	2013	46
7	Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis Journal of Cell Communication and Signaling ·Bruce L. Riser,Narasimharao Bhagavathula,Patricia Perone,吉雄渡辺,Yiru Xu,Gary J. Fisher,Feridoon Najmabadi,Durga Attili,James Varani	2012	7
8	CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease American Journal Of Pathology ·Bruce L. Riser,Feridoon Najmabadi,Bernard Perbal,Darryl R. Peterson,Spencer Canon,Oskar Bub,Bosmann Andreas,Herman Yeger,Heibe	2009	97
9	Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy Cytokine ·Frederick W.K. Tam,Bruce L. Riser,Karim Meeran,朝日新聞外報部,Charles D. Pusey,Andrew Frankel	2009	90
10	TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis American Journal of Physiology-Renal Physiology ·Laurinda A. Cooker,Darryl R. Peterson,朝日新聞外報部,Oskar Bub,Ingrid Bocris,Feridoon Najmabadi,David R. Brigstock,Bruce L. Riser	2007	48
11	Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary report Kidney International ·Bruce L. Riser,Pedro Cortés,Mark DeNichilo,Cathy Nace,Parminder S. Chahal,R.M Bozzai,Jerry Yee,D.V. Shagbazyan	2003	79
12	Putative subunits of the rat mesangial KATP: A type 2B sulfonylurea receptor and an inwardly rectifying K+ channel Kidney International ·Balázs Szamosfalvi,Pedro Cortés,Kyle P. Solivet,Kenichiro Asano,Bruce L. Riser,Peter A. Philip,Jerry Yee	2002	18
13	Modelling the effects of vascular stress in mesangial cells Current Opinion in Nephrology & Hypertension ·Bruce L. Riser,Pedro Cortés,Jerry Yee	2000	38
14	Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis Journal of the American Society of Nephrology ·Bruce L. Riser,Mark DeNichilo,Pedro Cortés,Brian Stapinski,H Emoto,Jerry Yee,Robert G. Narins	2000	341
15	Characterization of the rat mesangial cell type 2 sulfonylurea receptor Kidney International ·Kenichiro Asano,Pedro Cortés,Jeffrey L. Garvin,Bruce L. Riser,Alicia Rodríguez‐Barbero,Balázs Szamosfalvi,Indah Dwi Prafitasari	1999	8
16	TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain Kidney International ·Bruce L. Riser,Longyong Lin,Grecia Mishele Casaña Cuevas,Pedro Cortés,Kylie M. Drake,Christopher J. Guérin,Jerry Yee,D.W. Shimmin,Patricia R. Segarini,Robert G. Narins	1999	66
17	Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells Kidney International ·Pedro Cortés,Bruce L. Riser,Kenichiro Asano,Alicia Rodríguez‐Barbero,Robert G. Narins,Jerry Yee	1998	25
18	Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. PubMed ·Charles M. Heilig,Maria D. Portal Olea,Min Lee,Thais Umbelino,Bruce L. Riser,Frank C. Brosius,Patricia Cortés	1995	58
19	Mesangial cell killing by leukocytes: Role of leukocyte oxidants and proteolytic enzymes Kidney International ·James Varani,Carla G. Taylor,Bruce L. Riser,Dale K. Shumaker,Kai‐Wun Yeh,Michael K. Dame,Douglas Gibbs,Robert F. Todd,Francis Dumler,Judith Bromberg,Paul D. Killen	1992	24
20	Thrombospondin Binding by Keratinocytes: Modulation under Conditions which Alter Thrombospondin Biosynthesis Dermatology ·Bruce L. Riser,James Varani,Brian J. Nickoloff,Raj S. Mitra,Vishva M. Dixit	1990	6

About Bruce L. Riser

Bruce L. Riser is a scholar working on Nephrology, Rehabilitation, Molecular Biology, Pathology and Forensic Medicine and Biochemistry, having authored 53 papers that have together received 2.8k indexed citations. Recurring topics across this work include Connective Tissue Growth Factor Research (21 papers), Chronic Kidney Disease and Diabetes (9 papers), Parathyroid Disorders and Treatments (7 papers), Angiogenesis and VEGF in Cancer (5 papers), TGF-β signaling in diseases (5 papers), Biomarkers in Disease Mechanisms (4 papers), Wound Healing and Treatments (4 papers) and Heterotopic Ossification and Related Conditions (3 papers). The work is most often cited by research in Nephrology (915 citations), Clinical Biochemistry (249 citations), Immunology and Allergy (172 citations), Molecular Biology (1.5k citations) and Endocrinology, Diabetes and Metabolism (324 citations). Bruce L. Riser has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Pedro Cortés, Robert G. Narins, Jerry Yee, James Varani, Vishva M. Dixit, Mark DeNichilo, R S Mitra, B J Nickoloff, Francis Dumler and Jay Bernstein. Their work appears in journals such as Kidney International, Journal of Clinical Investigation, Journal of Cell Communication and Signaling, American Journal Of Pathology and Clinical & Experimental Metastasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact